Absci's technological prowess was further evidenced by its development of novel HIV antibodies that target a previously 'undruggable' region of the virus ... with Advanced Micro Devices (NASDAQ ...
Scientists led by the Institute of Nanotechnology in Italy, in collaboration with the ESRF, the European Synchrotron in Grenoble, France, have discovered how X-ray micro- and nano- tomography can ...
Scientists are struggling to create drugs which stop the HIV virus hiding inside our genomes. Image: picture alliance / Xinhua News Agency HIV is "like a time bomb," said James Riley, a ...
Updated Hep B Vaccine More Effective for People With HIV Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody ...
According to pediatric infectious disease physician Jason Brophy, with appropriate precautions it is possible for an HIV-positive mom to give birth without passing the virus on to the child.
A series of orders from the Trump administration have the potential to disrupt the delivery of life-saving medications to HIV ...
The new administration's freeze on foreign aid (affecting America's sweeping anti-HIV initiative PEPFAR) has raised concerns ...
Now, Muslimani draws on their own past to help others newly diagnosed with HIV navigate that journey. That includes many newcomers, each bringing their specific cultural context to the virus.
Milicent Muyoma has been turned away twice from the clinic where she collects her HIV medication in Mathare, an informal ...
HOOKIPA's development of HB-500 is part of a broader collaboration with Gilead that includes other therapies intended to provide functional cures for hepatitis B virus (HBV) and HIV-1. The company ...
While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...
South Africa remains a country with a substantial number of people living with HIV/AIDS with 18.90% of the population testing positive for the virus. These high rates have been attributed in part ...